Showing results (141-150 of 223) with videos related to
Sort By:
Pageof 23
Pediatric Blood & Cancer|April 28, 2017
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)James I Geller, John P Perentesis, Xiaowei Liu, et al.JACC. Cardiooncology|July 3, 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 ReportPurnima Singh, David K Crossman, Liting Zhou, et al.Journal of the National Cancer Institute|March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials dataMargaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412Kara L Davis, Elizabeth Fox, Emasenyie Isikwei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2017
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group StudyYael P Mossé, Stephan D Voss, Megan S Lim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium studyYael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.Cancer|April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaKristina A Cole, Heba Ijaz, Lea F Surrey, et al.Cancer|November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)James I Geller, Elizabeth Fox, Brian K Turpin, et al.Plos One|November 13, 2015
A Second Look at the Association between Gender and Mortality on Antiretroviral TherapySerena P Koenig, Alexandra Bornstein, Karine Severe, et al.British Journal of Haematology|March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.Pageof 23